Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bionexus Gene Lab Corp (BGLC)

Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bionexus Gene Lab Corp 10-2 TOWER B VERTICAL BUSINESS SUITE 8 JALAN KERINCHI KUALA LUMPUR N8 59200

www.bionexusgenelab.com P: 307-241-6898

Description:

BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia.

Key Statistics

Overview:

Market Capitalization, $K 9,080
Enterprise Value, $K 6,460
Shares Outstanding, K 17,668
Annual Sales, $ 9,770 K
Annual Net Income, $ -2,630 K
Last Quarter Sales, $ 2,380 K
Last Quarter Net Income, $ -100 K
EBIT, $ -2,620 K
EBITDA, $ -2,510 K
% of Insider Shareholders 6.84%
% of Institutional Shareholders 18.85%
Float, K 16,460
% Float 93.16%
Short Volume Ratio 0.44

Growth:

1-Year Return -95.24%
3-Year Return -97.96%
5-Year Return 0.00%
5-Year Revenue Growth 4,552.38%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 05/15/24
Next Earnings Date 08/21/24
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Year 574.45%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 07/20/23

BGLC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -30.74%
Return-on-Assets % -25.41%
Profit Margin % -26.92%
Debt/Equity 0.00
Price/Sales 0.96
Price/Cash Flow N/A
Price/Book 1.01
Book Value/Share 0.53
Interest Coverage -0.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar